»Print   »Share   »Bookmark

Heart & Vascular

  • PARADISE-MI: CLCZ696G2301: Prospective ARNI versus ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After Myocardial Infarction; Investigator: Jagdeep Sabharwal, MD
  • CONNECT HF: CLCZ696BUS05T Care Optimization through Patient and Hospital Engagement Clinical Trials for Heart Failure; Investigator: Matthew Weinberg, MD
  • ARTESiA: Apixaban for the Reduction of Thrombo-Embolism in Patients with Device-Detected Sub-Clinical Atrial Fibrillation; Investigator; Vicken Vorperian, MD

The following involves the use of a Humanitarian Use Device:

Title: GraftMaster RX Coronary Stent Graft for commercial use in selected patients through a Humanitarian Device Exemption; Primary Investigator: Lisa Schmitz, DO; Main Contact Dawn Minikel 262-928-3447